Pediatric Vaccine Global Market Opportunities And Strategies To 2033

Pediatric Vaccine Market 2025 – By Vaccine Type (Monovalent Vaccines, Multivalent Vaccines), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Conjugate Vaccines, Other Technologies), By Application (Infectious Disease, Allergy, Cancer, Pneumococcal Disease, Influenza, Measles, Mumps And Rubella, Other Applications), And By Region, Opportunities And Strategies – Global Forecast To 2034

Name: Pediatric Vaccine Global Market Opportunities And Strategies To 2033
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Pediatric Vaccine Global Market Opportunities And Strategies To 2033

Report Price : $4490.00 | Pages : 286 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Pediatric Vaccine Market Definition

Pediatric vaccines are immunizations specifically designed to protect children from various infectious diseases. These vaccines are administered during infancy and childhood from birth till 18 years. Moreover, these vaccines stimulate the immune system to recognize and combat pathogens, thereby preventing illnesses such as measles, mumps, rubella, polio and hepatitis.

The pediatric vaccine market consists of sales, by entities (organizations, sole traders and partnerships), of pediatric vaccine that are used by healthcare providers, including pediatricians, family physicians and public health clinics, who administer these vaccines according to established immunization schedules. Parents and guardians are also key stakeholders, ensuring their children receive timely vaccinations. Pediatric vaccines are typically administered during routine healthcare visits, starting from birth and continuing through adolescence, following schedules recommended by health authorities.

Book your 30 minutes free consultation with our research experts

Pediatric Vaccine Market Size

The global pediatric vaccine market reached a value of nearly $41,165.01 million in 2023, having grown at a compound annual growth rate (CAGR) of 6.71% since 2018. The market is expected to grow from $41,165.01 million in 2023 to $59,313.42 million in 2028 at a rate of 7.58%. The market is then expected to grow at a CAGR of 8.08% from 2028 and reach $87,467.55 million in 2033.

Growth in the historic period resulted from increasing birth rates in developing regions, increasing incidence of pediatric diseases, government and NGO funding, increasing mandatory vaccination policies. Factors that negatively affected growth in the historic period was high healthcare costs.

Going forward, increasing healthcare expenditure, rising incidence of chronic diseases among children, new vaccination awareness campaigns will drive the growth. Factor that could hinder the growth of the pediatric vaccine market in the future include shortage of healthcare professionals and supply chain disruptions.

Pediatric Vaccine Market Drivers

The key drivers of the pediatric vaccine market include:

Increasing healthcare expenditure

The increasing healthcare expenditure is expected to drive demand for pediatric vaccine going forward. Healthcare expenditure encompasses the total costs associated with medical services, healthcare products, public health programs and administrative activities within a given population or region. Healthcare expenditure is rising due to factors such as an aging population, increasing chronic diseases and escalating drug prices. Pediatric vaccines drive healthcare expenditure through investments in research, production, distribution, immunization programs and associated logistical and personnel costs. For instance, according to the economic forecast from the Office for Budget Responsibility (OBR) and Treasury, planned health spending in the UK is expected to rise to £192 billion ($244.43 billion) in 2024/25 from £182 billion ($231.70 billion) in 2022/23. However, due to inflation, this increase represents only a 0.6% rise in real terms compared to 2023/24 and a real-term reduction in funding compared to 2022/23. Additionally, in January 2024, according to National Health Expenditures Accounts (NHEA) by KFF, a US based independent source for health policy research, polling and journalism, health spending in the United States is expected to rise by 5% from 2023 to 2024, reaching $4.9 trillion. By 2030, out-of-pocket spending on retail prescription drugs is projected to total $48.1 billion. The increasing healthcare expenditure, especially in the developing economies, is expected to generate high demand for the pediatric vaccine market.

Pediatric Vaccine Market Restraints

The key restraints on the pediatric vaccine market include:

Shortage of Healthcare Professionals

Shortage of healthcare professionals are expected to restrict the growth of the pediatric vaccine market going forward. The shortage of healthcare professionals is a complex issue driven by various factors, including an aging workforce, insufficient training capacity and burnout and job stress. The shortage of healthcare professionals, who play a crucial role in educating parents and caregivers about the importance of vaccinations and addressing concerns, may lead to increased misinformation and vaccine hesitancy, further limiting vaccine adoption. For instance, in May 2024, according to World Health Organization, Switzerland-based, agency of the United Nations, there are approximately 29 million nurses and 2.2 million midwives globally, with the WHO projecting a shortage of 4.5 million nurses and 310,000 midwives by 2030. Therefore, the shortage of healthcare professionals may hinder the growth of the pediatric vaccine market.

Pediatric Vaccine Market Trends

Major trends shaping the pediatric vaccine market include:

Developing New Pediatric Vaccines For Better Public Health Outcomes

Major companies operating in the pediatric vaccine market are focusing on developing new vaccines for better public health outcomes. These vaccines, often included in national schedules, boost awareness and adoption among parents and healthcare providers. For example, in September 2024, Immunologicals Limited, an India-based pharmaceutical company specializing in vaccines and immunological products, launched Havisure Hepatitis A vaccine. Havisure Hepatitis A is a vaccine developed for pediatric use, offered in a 0.5 ml dosage to protect children against Hepatitis A, a highly contagious liver infection. This vaccine represents a significant step in India's commitment to providing affordable and effective immunization, particularly for vulnerable groups such as children. Its launch supports India's "Make in India" initiative, enhancing the country's vaccine self-sufficiency and contributing to better public health outcomes.

Advancements In Conjugate Vaccines For Protecting Children Against Pneumococcal Disease

Companies operating in the pediatric vaccine market are focused on the development of conjugate vaccines to improve the immune response in children. Conjugate vaccines are vaccines that attach a pathogen's polysaccharide to a protein carrier to strengthen the immune response, especially in young children. For instance, In April 2023, Pfizer Inc., a US-based pharmaceutical company, received U.S. Food and Drug Administration approval for PREVNAR 20, a 20-valent pneumococcal conjugate vaccine developed to protect against invasive pneumococcal diseases caused by 20 different serotypes of Streptococcus pneumoniae. Approved for use in infants and children as young as six weeks, it provides the most extensive serotype coverage of any pediatric pneumococcal vaccine. In addition to the seven serotypes found in PREVNAR 13, PREVNAR 20 also targets seven additional serotypes that are linked to antibiotic resistance and more severe disease. This vaccine helps prevent serious infections such as pneumonia, meningitis and otitis media, reducing the overall burden of pneumococcal disease in young children. Additionally, in June 2022, Merck & Co. Inc., a US-based pharmaceutical company, received U.S. Food and Drug Administration approval for VAXNEUVANCE, a pneumococcal conjugate vaccine designed to protect against infections caused by Streptococcus pneumoniae, a bacterium responsible for serious diseases such as pneumonia, meningitis and bacteremia. It provides immunity against 15 serotypes of the bacteria and is intended for use in adults and children aged 6 weeks and older.

Opportunities And Recommendations In The Pediatric Vaccine Market

Opportunities – The top opportunities in the pediatric vaccine market segmented by vaccine type will arise in the monovalent segment, which will gain $12,227.58 million of global annual sales by 2028. The top opportunities in the pediatric vaccine market segmented by technology will arise in the conjugate segment, which will gain $6,831.96 million of global annual sales by 2028. The top opportunities in the pediatric vaccine market segmented by application will arise in the infectious disease segment, which will gain $5,501.16 million of global annual sales by 2028. The pediatric vaccine market size will gain the most in the USA at $6,375.70 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the pediatric vaccine companies to focus on developing targeted pediatric vaccines, focus on expanding conjugate vaccine development, focus on expanding pediatric vaccine portfolios, focus on multivalent pediatric vaccines, focus on live attenuated pediatric vaccines, expand in emerging markets, focus on expanding distribution channels to reach broader demographics, focus on pricing strategies for pediatric vaccine companies, leverage digital channels, strengthen healthcare provider outreach and focus on infectious disease market and pediatric vaccine development.

Pediatric Vaccine Market Segmentation

The pediatric vaccine market is segmented by vaccine type, by technology and by application.

By Vaccine Type –
The pediatric vaccine market is segmented by vaccine type into:

a) Monovalent Vaccines
b) Multivalent Vaccines

The monovalent market was the largest segment of the pediatric vaccine market segmented by vaccine type, accounting for 70.69% or $29,099.11 million of the total in 2023. Going forward, the multivalent segment is expected to be the fastest growing segment in the pediatric vaccine market segmented by vaccine type, at a CAGR of 8.31% during 2023-2028.

By Technology –
The pediatric vaccine market is segmented by technology into:

a) Live Attenuated Vaccines
b) Inactivated Vaccines
c) Toxoid Vaccines
d) Conjugate Vaccines
e) Other Technologies

The conjugate market was the largest segment of the pediatric vaccine market segmented by technology, accounting for 37.08% or $15,266.04 million of the total in 2023. Going forward, the other technologies segment is expected to be the fastest growing segment in the pediatric vaccine market segmented by technology, at a CAGR of 7.75% during 2023-2028.

By Application –
The pediatric vaccine market is segmented by application into:

a) Infectious Disease
b) Allergy
c) Cancer
d) Pneumococcal Disease
e) Influenza
f) Measles
g) Mumps And Rubella
h) Other Applications

The infectious disease market was the largest segment of the pediatric vaccine market segmented by application, accounting for 35.69% or $14,692.79 million of the total in 2023. Going forward, the measles, mumps and rubella segment is expected to be the fastest growing segment in the pediatric vaccine market segmented by application, at a CAGR of 9.19% during 2023-2028.

By Geography - The pediatric vaccine market is segmented by geography into:

• China
• India
• Japan
• Australia
• Indonesia
• South Korea

• USA
• Canada

• Brazil

• France
• Germany
• UK
• Italy
• Spain

• Russia

North America was the largest region in the pediatric vaccine market, accounting for 41.42% or $17,050.97 million of the total in 2023. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the pediatric vaccine market will be Asia Pacific and Africa where growth will be at CAGRs of 9.05% and 8.25% respectively. These will be followed by Middle East and South America where the markets are expected to grow at CAGRs of 7.94% and 7.90% respectively.

Pediatric Vaccine Market Competitive Landscape

Major Competitors are:

Merck & Co.Inc.

SANOFI S.A.

Pfizer, Inc.

Seqirus (CSL Limited)

GlaxoSmithKline plc.

Other Competitors Include:

Johnson & Johnson

Daiichi Sankyo Co. Ltd.

Novavax, Inc.

AstraZeneca Plc.

Novartis AG

Maruho Co., Ltd.

Indian Immunologicals Limited (IIL)

Sinovac Biotech Ltd.

Sinopharm Group

Chongqing Zhifei Biological Products Co., Ltd.

Walvax Biotechnology Co., Ltd.

Hualan Biological Engineering Inc.

Beijing Tiantan Biological Products Corp.

Shenzhen Kangtai Biological Products Co., Ltd.

GSK

Sanofi Pasteur

Moderna

Eli Lilly's Taltz

Baxter Corporation

Laboratorios Silanes

Instituto Pasteur México

Emergent BioSolutions

Dynavax Technologies Corporation

International Finance Corporation (IFC)

Vaxart, Inc.

Takeda

Instituto Butantan

Biofarma

Laboratorio Pfeiffer

Laboratório São Paulo

DP World

Shifavaccine

BioMedical Ltd.

Lifera

Arabio

ediWound Ltd.

Koçak Farma

Abdi Ibrahim

Julphar Gulf Pharmaceutical Industries

Aspen Pharmacare

Vacsera

May & Baker Nigeria Plc.

Evans Medical Plc.

1 Executive Summary

1.1 Pediatric Vaccine – Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition

6.2 Summary

6.3 Pediatric Vaccine Market Definition And Segmentations

6.4 Market Segmentation By Vaccine Type

6.4.1 Monovalent Vaccines

6.4.2 Multivalent Vaccines

6.5 Market Segmentation By Technology

6.5.1 Live Attenuated Vaccines

6.5.2 Inactivated Vaccines

6.5.3 Toxoid Vaccines

6.5.4 Conjugate Vaccines

6.5.5 Other Technologies

6.6 Market Segmentation By Application

6.6.1 Infectious Disease

6.6.2 Allergy

6.6.3 Cancer

6.6.4 Pneumococcal Disease

6.6.5 Influenza

6.6.6 Measles, Mumps And Rubella (MMR)

6.6.7 Other Applications

7 Major Market Trends

7.1 Developing New Pediatric Vaccines For Better Public Health Outcomes

7.2 Advancements In Conjugate Vaccines For Protecting Children Against Pneumococcal Disease

7.3 Innovative Inactivated Poliovirus Vaccine Aids Polio Eradication Programs

8 Pediatric Vaccine Market – Macro-Economic Scenario

8.1 COVID-19 Impact On The Pediatric Vaccine Market

8.2 Impact Of The War In Ukraine On The Pediatric Vaccine Market

8.3 Impact Of High Inflation On The Pediatric Vaccine Market

9 Global Market Size and Growth

9.1 Market Size

9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

9.2.1 Market Drivers 2018 – 2023

9.2.2 Market Restraints 2018 – 2023

9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

9.3.1 Market Drivers 2023 – 2028

9.3.2 Market Restraints 2023 – 2028

10 Global Pediatric Vaccine Market Segmentation

10.1 Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

10.2 Global Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

10.3 Global Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

11 Pediatric Vaccine Market, Regional and Country Analysis

11.1 Global Pediatric Vaccine Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

11.2 Global Pediatric Vaccine Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary

12.2 Market Overview

12.2.1 Region Information

12.2.2 Market Information

12.2.3 Background Information

12.2.4 Government Initiatives

12.2.5 Regulations

12.2.6 Regulatory Bodies

12.2.7 Major Associations

12.2.8 Taxes Levied

12.2.9 Corporate Tax Structure

12.2.10 Investments

12.2.11 Major Companies

12.3 Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.4 Asia-Pacific Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.5 Asia-Pacific Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.6 Asia-Pacific Pediatric Vaccine Market: Country Analysis

12.7 China Market

12.8 Summary

12.9 Market Overview

12.9.1 Country Information

12.9.2 Market Information

12.9.3 Background Information

12.9.4 Government Initiatives

12.9.5 Regulations

12.9.6 Regulatory Bodies

12.9.7 Major Associations

12.9.8 Taxes Levied

12.9.9 Corporate Tax Structure

12.9.10 Investments

12.9.11 Major Companies

12.10 China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.11 China Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.12 China Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.13 India Market

12.14 India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.15 India Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.16 India Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.17 Japan Market

12.18 Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.19 Japan Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.20 Japan Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.21 Australia Market

12.22 Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.23 Australia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.24 Australia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.25 Indonesia Market

12.26 Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.27 Indonesia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.28 Indonesia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.29 South Korea Market

12.30 South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.31 South Korea Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

12.32 South Korea Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary

13.2 Market Overview

13.2.1 Region Information

13.2.2 Market Information

13.2.3 Background Information

13.2.4 Government Initiatives

13.2.5 Regulations

13.2.6 Regulatory Bodies

13.2.7 Major Associations

13.2.8 Taxes Levied

13.2.9 Corporate tax structure

13.2.10 Investments

13.2.11 Major Companies

13.3 Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.4 Western Europe Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.5 Western Europe Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.6 UK Market

13.7 UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.8 UK Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.9 UK Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.10 Germany Market

13.11 Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.12 Germany Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.13 Germany Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.14 France Market

13.15 France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.16 France Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.17 France Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.18 Italy Market

13.19 Italy Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.20 Italy Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.21 Italy Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.22 Spain Market

13.23 Spain Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.24 Spain Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

13.25 Spain Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary

14.2 Market Overview

14.2.1 Region Information

14.2.2 Market Information

14.2.3 Background Information

14.2.4 Government Initiatives

14.2.5 Regulations

14.2.6 Regulatory Bodies

14.2.7 Major Associations

14.2.8 Taxes Levied

14.2.9 Corporate Tax Structure

14.2.10 Major companies

14.3 Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.4 Eastern Europe Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.5 Eastern Europe Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.6 Eastern Europe Pediatric Vaccine Market: Country Analysis

14.7 Russia Market

14.8 Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.9 Russia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

14.10 Russia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary

15.2 Market Overview

15.2.1 Region Information

15.2.2 Market Information

15.2.3 Background Information

15.2.4 Government Initiatives

15.2.5 Regulations

15.2.6 Regulatory Bodies

15.2.7 Major Associations

15.2.8 Taxes Levied

15.2.9 Corporate Tax Structure

15.2.10 Investments

15.2.11 Major Companies

15.3 North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.4 North America Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.5 North America Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.6 North America Pediatric Vaccine Market: Country Analysis

15.7 USA Market

15.8 Summary

15.9 Market Overview

1.1.1 Country Information

1.1.2 Market Information

1.1.3 Background Information

1.1.4 Government Initiatives

1.1.5 Regulations

1.1.6 Regulatory Bodies

1.1.7 Major Associations

1.1.8 Taxes Levied

1.1.9 Corporate Tax Structure

1.1.10 Investments

1.1.11 Major Companies

15.10 USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.11 USA Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.12 USA Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.13 Canada Market

15.14 Canada Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.15 Canada Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

15.16 Canada Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary

16.2 Market Overview

16.2.1 Region Information

16.2.2 Market Information

16.2.3 Background Information

16.2.4 Government Initiatives

16.2.5 Regulations

16.2.6 Regulatory Bodies

16.2.7 Major Associations

16.2.8 Taxes Levied

16.2.9 Corporate Tax Structure

16.2.10 Investments

16.2.11 Major Companies

16.3 South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.4 South America Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.5 South America Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.6 South America Pediatric Vaccine Market: Country Analysis

16.7 Brazil Market

16.8 Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.9 Brazil Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

16.10 Brazil Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary

17.2 Market Overview

17.2.1 Region Information

17.2.2 Market Information

17.2.3 Background Information

17.2.4 Government Initiatives

17.2.5 Regulations

17.2.6 Regulatory Bodies

17.2.7 Major Associations

17.2.8 Taxes Levied

17.2.9 Corporate Tax Structure

17.2.10 Investments

17.2.11 Major Companies

17.3 Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17.4 Middle East Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

17.5 Middle East Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary

18.2 Market Overview

18.2.1 Region Information

18.2.2 Market Information

18.2.3 Background Information

18.2.4 Government Initiatives

18.2.5 Regulations

18.2.6 Regulatory Bodies

18.2.7 Major Associations

18.2.8 Taxes Levied

18.2.9 Corporate Tax Structure

18.2.10 Investments

18.2.11 Major Companies

18.3 Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18.4 Africa Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

18.5 Africa Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape and Company Profiles

19.1 Company Profiles

19.2 Merck & Co., Inc.

19.2.1 Company Overview

19.2.2 Products And Services

19.2.3 Business Strategy

19.2.4 Financial Overview

19.3 Sanofi S.A.

19.3.1 Company Overview

19.3.2 Products And Services

19.3.3 Business Strategy

19.3.4 Financial Overview

19.4 Pfizer Inc

19.4.1 Company Overview

19.4.2 Products And Services

19.4.3 Business Strategy

19.4.4 Financial Overview

19.5 Seqirus (CSL Limited)

19.5.1 Company Overview

19.5.2 Products And Services

19.5.3 Business Strategy

19.5.4 Financial Overview

19.6 GlaxoSmithKline plc

19.6.1 Company Overview

19.6.2 Products And Services

19.6.3 Financial Overview

20 Other Major And Innovative Companies

20.1 Johnson & Johnson

20.1.1 Company Overview

20.1.2 Products And Services

20.2 Daiichi Sankyo Co. Ltd

20.2.1 Company Overview

20.2.2 Products And Services

20.3 Novavax, Inc

20.3.1 Company Overview

20.3.2 Products And Services

20.4 AstraZeneca Plc

20.4.1 Company Overview

20.4.2 Products And Services

20.5 Novartis AG

20.5.1 Company Overview

20.5.2 Products And Services

20.6 BioNTech

20.6.1 Company Overview

20.6.2 Products And Services

20.7 Zydus Lifesciences Limited

20.7.1 Company Overview

20.7.2 Products And Services

20.8 Walvax Biotechnology Co. Ltd

20.8.1 Company Overview

20.8.2 Products And Services

20.9 Indian Immunologicals Limited

20.9.1 Company Overview

20.9.2 Products And Services

20.10 Sinovac Biotech Ltd

20.10.1 Company Overview

20.10.2 Products And Services

20.11 Serum Institute of India

20.11.1 Company Overview

20.11.2 Products And Services

20.12 Ezequiel Dias Foundation (FUNED)

20.12.1 Company Overview

20.12.2 Products And Services

20.13 Bharat Biotech International Limited

20.13.1 Company Overview

20.13.2 Products And Services

20.14 Panacea Biotec

20.14.1 Company Overview

20.14.2 Products And Services

20.15 MCM Vaccine B.V

20.15.1 Company Overview

20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 SK bioscience Acquired IDT Biologika

23.2 GlaxoSmithKline Public Limited Company Acquired Affinivax Inc

24 Opportunities And Strategies

24.1 Global Pediatric Vaccine Market In 2028 – Countries Offering Most New Opportunities

24.2 Global Pediatric Vaccine Market In 2028 – Segments Offering Most New Opportunities

24.3 Global Pediatric Vaccine Market In 2028 – Growth Strategies

24.3.1 Market Trend Based Strategies

24.3.2 Competitor Strategies

25 Pediatric Vaccine Market, Conclusions And Recommendations

25.1 Conclusions

25.2 Recommendations

25.2.1 Product

25.2.2 Place

25.2.3 Price

25.2.4 Promotion

25.2.5 People

26 Appendix

26.1 Geographies Covered

26.2 Market Data Sources

26.3 Research Methodology

26.4 Currencies

26.5 The Business Research Company

26.6 Copyright and Disclaimer

List Of Tables

Table 1: Global Pediatric Vaccine Market, Historic, 2018 – 2023, $ Million

Table 2: Global Pediatric Vaccine Market, Forecast, 2023 – 2028, 2033F, $ Million

Table 3: Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 4: Global Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 5: Global Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 6: Global Pediatric Vaccine Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 7: Global Pediatric Vaccine Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 8: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $

Table 9: Asia-Pacific Population, By Country, 2018-2028, Millions

Table 10: Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 11: Asia-Pacific Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 12: Asia-Pacific Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 13: China GDP Per Capita, 2018-2023, $

Table 14: China Population, 2018-2028, Millions

Table 15: China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 16: China Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 17: China Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 18: India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 19: India Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 20: India Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 21: Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 22: Japan Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 23: Japan Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 24: Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 25: Australia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 26: Australia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 27: Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 28: Indonesia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 29: Indonesia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 30: South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 31: South Korea Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 32: South Korea Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 33: Western Europe GDP Per Capita, By Country, 2018-2023, $

Table 34: Western Europe Population, By Country, 2018-2028, Millions

Table 35: Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 36: Western Europe Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 37: Western Europe Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 38: UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 39: UK Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 40: UK Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 41: Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 42: Germany Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 43: Germany Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 44: France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 45: France Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 46: France Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 47: Italy Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 48: Italy Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 49: Italy Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 50: Spain Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 51: Spain Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 52: Spain Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 53: Eastern Europe GDP Per Capita, By Country, 2018-2023, $

Table 54: Eastern Europe Population, By Country, 2018-2028, Millions

Table 55: Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 56: Eastern Europe Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 57: Eastern Europe Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 58: Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 59: Russia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 60: Russia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 61: North America GDP Per Capita, By Country, 2018-2023, $

Table 62: North America Population, By Country, 2018-2028, Millions

Table 63: North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 64: North America Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 65: North America Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 66: USA GDP Per Capita, 2018-2023, $

Table 67: USA Population, 2018-2028, Millions

Table 68: USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 69: USA Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 70: USA Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 71: Canada Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 72: Canada Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 73: Canada Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 74: South America GDP Per Capita, By Country, 2018-2023, $

Table 75: South America Population, By Country, 2018-2028, Millions

Table 76: South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 77: South America Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 78: South America Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 79: Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 80: Brazil Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 81: Brazil Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 82: Middle East GDP Per Capita, By Country, 2018-2023, $

Table 83: Middle East Population, By Country, 2018-2028, Millions

Table 84: Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 85: Middle East Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 86: Middle East Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 87: Africa GDP Per Capita, By Country, 2018-2023, $

Table 88: Africa Population, By Country, 2018-2028, Millions

Table 89: Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 90: Africa Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 91: Africa Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Table 92: Global Pediatric Vaccine Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)

Table 93: Merck & Co., Inc – Financial Overview, 2019 – 2023, $Billion

Table 94: Sanofi S.A. – Financial Overview, 2019 – 2023, $Billion

Table 95: Pfizer Inc – Financial Overview, 2019 – 2023, $Billion

Table 96: Seqirus (CSL Limited) – Financial Overview, 2019 – 2023, $Billion

Table 97: GlaxoSmithKline plc – Financial Overview, 2019 – 2023, $ Billion

Table 98: Pediatric Vaccine Market, Competitive Benchmarking (In USD Millions)

Table 99: Pediatric Vaccine Market, Competitive Dashboard

Table 100: Global Pediatric Vaccine Market Size Gain ($ Million), 2023 – 2028, By Country

Table 101: Global Pediatric Vaccine Market Size Gain ($ Million), Segmentation By Vaccine Type, 2023 – 2028

Table 102: Global Pediatric Vaccine Market Size Gain ($ Million), Segmentation By Technology, 2023 – 2028

Table 103: Global Pediatric Vaccine Market Size Gain ($ Million), Segmentation By Application, 2023 – 2028

Table 104: Pediatric Vaccine Market Data Sources

List Of Figures

Figure 1: Global Pediatric Vaccine Market Segmentation By Vaccine Type

Figure 2: Global Pediatric Vaccine Market Segmentation By Technology

Figure 3: Global Pediatric Vaccine Market Segmentation By Application

Figure 4: Global Pediatric Vaccine Market, Historic, 2018 – 2023, $ Million

Figure 5: Global Pediatric Vaccine Market, Forecast, 2023 – 2028, 2033F, $ Million

Figure 6: Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 7: Global Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 8: Global Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 9: Global Pediatric Vaccine Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 10: Global Pediatric Vaccine Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 11: Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 12: Asia-Pacific Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 13: Asia-Pacific Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 14: China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 15: China Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 16: China Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 17: India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 18: India Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 19: India Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 20: Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 21: Japan Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 22: Japan Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 23: Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 24: Australia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 25: Australia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 26: Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 27: Indonesia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 28: Indonesia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 29: South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 30: South Korea Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 31: South Korea Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 32: Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 33: Western Europe Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 34: Western Europe Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 35: UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 36: UK Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 37: UK Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 38: Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 39: Germany Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 40: Germany Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 41: France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 42: France Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 43: France Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 44: Italy Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 45: Italy Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 46: Italy Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 47: Spain Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 48: Spain Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 49: Spain Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 50: Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 51: Eastern Europe Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 52: Eastern Europe Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 53: Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 54: Russia Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 55: Russia Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 56: North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 57: North America Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 58: North America Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 59: USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 60: USA Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 61: USA Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 62: Canada Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 63: Canada Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 64: Canada Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 65: South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 66: South America Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 67: South America Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 68: Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 69: Brazil Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 70: Brazil Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 71: Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 72: Middle East Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 73: Middle East Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 74: Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 75: Africa Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 76: Africa Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million

Figure 77: Global Pediatric Vaccine Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)

Figure 78: Merck & Co., Inc – Financial Overview, 2019 – 2023, $ Billion

Figure 79: Sanofi S.A. – Financial Overview, 2019 – 2023, $ Billion

Figure 80: Pfizer Inc – Financial Overview, 2019 – 2023, $ Billion

Figure 81: Seqirus (CSL Limited) – Financial Overview, 2019 – 2023, $ Billion

Figure 82: GlaxoSmithKline plc – Financial Overview, 2019 – 2023, $ Billion

Figure 83: Geographic Regions Covered

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the pancreatic cancer drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the fertility drugs market research report 2022 with industry size, share, segments and market growth

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Intravenous, Intranasal/ Inhalation), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter Drugs, Prescription-Based Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine, Therapeutic Nutrients And Mineralsa) Cardiovascular Drugs Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti-Thrombotic, Angina Pectoris, Congestive Heart Failure, Other Cardiovascular Drugsb) Dermatology Drugs Type (Acne Drugs, Dermatitis Drugs, Psoriasis Drugs, Other Drugs For Dermatology Diseasesc) Gastrointestinal Drugs Type (Antacids, Antiulcerants, Antiemetics And Antinauseants, Antidiarrhealsd) Genito-Urinary Drugs Type (Hormonal Contraceptives, Drugs For Benign Prostatic Hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction

View Report

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Other Oncology Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, Other Distribution Channels), By Route Of Administration (Oral, Parental, Other Route Of Administration), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Frequently Asked Questions

What is the definition of the pediatric vaccine market?

The pediatric vaccines market consists of sales of pediatric vaccines and its related services used to provide immunity to infants and children for specific diseases. The pediatric vaccine is a preparation of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are administered to stimulate the production of antibodies and provide immunity against one or several diseases among children. request a sample here

How will the pediatric vaccine market drivers and restraints affect pediatric vaccine market dynamics? What forces will shape the pediatric vaccine industry going forward?

The pediatric vaccines market growth is aided by rising prevalence of chronic diseases. However, some pediatric vaccines market restraints include vaccine refusal by parents for their children request a sample here

What is the forecast market size of the pediatric vaccine market?

The pediatric vaccines market forecast is expected to reach $49.9 billion in 2025 at a compound annual growth rate of 11.4%. request a sample here

How is the pediatric vaccine market segmented?

The global pediatric vaccine market is segmented -
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer request a sample here

Which region has largest share, and what is the market size and growth by geography according to the pediatric vaccine global market report?

For more detail on this, request a sample here.

Who are the key players of the global pediatric vaccine market?

Top competitors in the pediatric vaccines market are GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., P request a sample here.

What are the key trends in the global pediatric vaccine market?

Major trends influencing the pediatric vaccines market include demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g. tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations request a sample here.

What are the major opportunities in the pediatric vaccine market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global pediatric vaccine market, request a sample here.

How does the pediatric vaccine market relate to the overall economy and other similar markets?

request a sample here.